We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Internet Application Furthers Pediatric Cancer Research

By LabMedica International staff writers
Posted on 11 Jan 2016
Print article
Image: Researchers have developed a powerful interactive web application and data set tool to advance understanding of the mutations that lead to and fuel pediatric cancer (Photo courtesy of St. Jude Children\'s Research Hospital).
Image: Researchers have developed a powerful interactive web application and data set tool to advance understanding of the mutations that lead to and fuel pediatric cancer (Photo courtesy of St. Jude Children\'s Research Hospital).
An interactive web application and dataset that is a powerful tool to advance understanding of oncogenic mutations is available free of charge to pediatric cancer researchers.

The ProteinPaint web application was developed and is maintained by investigators at St. Jude Children's Research Hospital (Memphis, TN, USA). ProteinPaint integrates mutation information from multiple datasets obtained from the St. Jude Children's Research Hospital, the Washington University (St. Louis, MO, USA) Pediatric Cancer Genome Project, the [US] National Cancer Institute's (Bethesda, MD, USA) Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative, and other published pediatric cancer studies.

Having access to this vast data base enables the program to identify mutations that are present only at diagnosis or at relapse, and to indicate whether the mutations occur in almost every cell (germline) or just cancer cells (somatic).

The ProteinPaint program, which was described in the December 29, 2015, online edition of the journal Nature Genetics, currently includes information on almost 27,500 mutations discovered in more than 1,000 pediatric patients with 21 cancer subtypes.

"Each day brings new information about mutations that drive human cancer. Novel tools are essential to help scientists use this wealth of genomic data to advance research and find new cures," said senior author Dr. Jinghui Zhang, professor of computational biology at St. Jude Children's Research Hospital. "We developed ProteinPaint as an intuitive tool any scientist can easily use to explore the vast amount of information now available on cancer genomics."

"ProteinPaint's focus on pediatric cancer and presentation of mutations at the gene level complements existing cancer genome data portals," said Dr. Zhang. "For St. Jude, the application is the foundation for developing a global reference database for information about pediatric cancer."

Related Links:

ProteinPaint - available to researchers free of charge
St. Jude Children's Research Hospital
Washington University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.